Autolus Therapeutics Plc (AUTL)
1.61
+0.12
(+8.05%)
USD |
NASDAQ |
Apr 16, 16:00
1.615
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Cash from Investing (Quarterly) : 86.65M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Mereo BioPharma Group Plc | 0.00 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.0656M |
| Bicycle Therapeutics Plc | -0.5731M |
| DBV Technologies SA | -0.7165M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -67.21M |
| Cash from Financing (Quarterly) | -1.798M |
| Free Cash Flow | -311.43M |
| Free Cash Flow Per Share (Quarterly) | -0.2491 |
| Free Cash Flow to Equity (Quarterly) | -92.69M |
| Free Cash Flow to Firm (Quarterly) | -43.78M |
| Free Cash Flow Yield | -72.68% |